Login
|
Register
News
Media
Insights
Peer Exchange
OncNurse TV
Webinars
Podcasts
Resources
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancers
Supportive Care
Blood Cancers
Prevention
Genetics
Nurse Navigation
Immuno-Oncology
Drug Safety
Skin Cancer/Melanoma
Brain Cancer
Childhood/AYA Cancer
Head and Neck Cancers
Adverse Event Management
Contributors
Conferences
Partners
Advocacy
Associations
Schools of Nursing
Publications
CE
Register now to learn about a new option for relapsed or refractory follicular lymphoma
Breast Cancer
Study Shows Need for Evidence-Based, Educational Material for Providers and Patients with Metastatic Breast Cancer
BY KEVIN WRIGHT
Nurse Navigators Play a Vital Role for Breast Cancer Patients in the Oncology Clinic
BY JESSICA SKARZYNSKI
Prior CINV May Increase Occurrence in Later Cycles of Cancer Treatment
BY BRIELLE BENYON
Asian Patients With HR+, HER2- Breast Cancer Have Higher Recurrence Risk
BY KRISTI ROSA
FDA Approves Pembrolizumab Plus Chemo for TNBC
BY BRIELLE BENYON
A Rundown of New Infusion Therapies
BY BRIELLE BENYON
Triple-Negative Breast Cancer Treatments Continue to Evolve
BY HAYLEY VIRGIL
Nurses' Role in Cardiotoxicity in Cancer Survivors
BY BRIELLE BENYON
Navigating Breast Cancer Care During a Pandemic
BY CANCER
CARE
FDA Advancements in HER2+ Breast Cancer
<< Prev Page
Next Page >>
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources
Newsroom
Continuing Education
Discussions
Web Exclusives
About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.